These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8629675)
41. Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years. Rapoport AP; DiPersio JF; Martin BA; Duerst RE; Kouides PA; Liesveld JL; Abboud CN; Packman CH; Eberly SW; Sherman M Bone Marrow Transplant; 1995 Apr; 15(4):523-30. PubMed ID: 7655376 [TBL] [Abstract][Full Text] [Related]
42. An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors. European Group for Blood and Marrow Transplantation. Gahrton G; Tura S; Ljungman P; Bladé J; Cavo M; De Laurenzi A; Façon T; Gratwohl A; Michallet M; Nikoskelainen J Stem Cells; 1995 Aug; 13 Suppl 2():122-5. PubMed ID: 8520500 [TBL] [Abstract][Full Text] [Related]
43. Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors. Lundberg JH; Hansen RM; Chitambar CR; Lawton CA; Gottlieb M; Anderson T; Ash RC J Clin Oncol; 1991 Oct; 9(10):1848-59. PubMed ID: 1919635 [TBL] [Abstract][Full Text] [Related]
44. Bone marrow transplantation for thalassemia. Experience in Pesaro, Italy. Giardini C; Angelucci E; Lucarelli G; Galimberti M; Polchi P; Baronciani D; Bechelli G Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):6-10. PubMed ID: 8311174 [TBL] [Abstract][Full Text] [Related]
45. Allogeneic bone marrow transplantation for multiple myeloma. Ballester OF Semin Oncol; 1993 Oct; 20(5 Suppl 6):67-71. PubMed ID: 8211218 [TBL] [Abstract][Full Text] [Related]
46. Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation. Abrams RA; Liu PJ; Ambinder RF; Haulk TL; Korman LT; Herman MG; Jones RJ Radiology; 1997 Jun; 203(3):865-70. PubMed ID: 9169718 [TBL] [Abstract][Full Text] [Related]
47. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data. Chopra R; Goldstone AH; Pearce R; Philip T; Petersen F; Appelbaum F; De Vol E; Ernst P J Clin Oncol; 1992 Nov; 10(11):1690-5. PubMed ID: 1403052 [TBL] [Abstract][Full Text] [Related]
48. Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Kyriakou C; Canals C; Cornelissen JJ; Socié G; Willemze R; Ifrah N; Greinix HT; Blaise D; Deconinck E; Ferrant A; Schattenberg A; Harousseau JL; Sureda A; Schmitz N J Clin Oncol; 2010 Nov; 28(33):4926-34. PubMed ID: 20956626 [TBL] [Abstract][Full Text] [Related]
49. Allogeneic bone marrow transplantation for low-grade lymphoma. van Besien K; Sobocinski KA; Rowlings PA; Murphy SC; Armitage JO; Bishop MR; Chaekal OK; Gale RP; Klein JP; Lazarus HM; McCarthy PL; Raemaekers JM; Reiffers J; Phillips GL; Schattenberg AV; Verdonck LF; Vose JM; Horowitz MM Blood; 1998 Sep; 92(5):1832-6. PubMed ID: 9716615 [TBL] [Abstract][Full Text] [Related]
50. [Bone marrow transplantation. Preliminary results]. Pimentel P; de Lacerda JM Acta Med Port; 1991 Dec; 4 Suppl 1():39S-43S. PubMed ID: 1805531 [TBL] [Abstract][Full Text] [Related]
51. Bone marrow transplantation: a children's hospital of New Orleans experience. Yu LC; Ode D; Warrier RP J La State Med Soc; 1993 Feb; 145(2):57-8, 61-4. PubMed ID: 8440960 [TBL] [Abstract][Full Text] [Related]
52. Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. Gahrton G; Tura S; Ljungman P; Bladé J; Brandt L; Cavo M; Façon T; Gratwohl A; Hagenbeek A; Jacobs P J Clin Oncol; 1995 Jun; 13(6):1312-22. PubMed ID: 7751876 [TBL] [Abstract][Full Text] [Related]
53. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Dalle S; Beylot-Barry M; Bagot M; Lipsker D; Machet L; Joly P; Dompmartin A; d'Incan M; Maubec E; Grange F; Dereure O; Prey S; Barete S; Wetterwald M; Fraitag S; Petrella T Br J Dermatol; 2010 Jan; 162(1):74-9. PubMed ID: 19689477 [TBL] [Abstract][Full Text] [Related]
54. [Prognostic significance of histobiopsy findings in bone marrow of malignant lymphomas in adults]. Günther C; Püschel W; Helbig W; Schwenke H; Kubel M; Hoffmann FA; Schultze W Z Gesamte Inn Med; 1982 Aug; 37(15):491-7. PubMed ID: 7148046 [TBL] [Abstract][Full Text] [Related]
55. Delayed complications and long-term effects after bone marrow transplantation. Deeg HJ Hematol Oncol Clin North Am; 1990 Jun; 4(3):641-57. PubMed ID: 2193016 [TBL] [Abstract][Full Text] [Related]
56. Biology and treatment of small non-cleaved cell lymphoma. Magrath IT; Shiramizu B Oncology (Williston Park); 1989 Nov; 3(11):41-53; discussion 53-4, 56, 59-60. PubMed ID: 2578020 [TBL] [Abstract][Full Text] [Related]
58. Long term results of allogeneic bone marrow transplantation. Gluckman E; Socié G Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S71-3. PubMed ID: 8177720 [TBL] [Abstract][Full Text] [Related]
59. Late complications after allogeneic bone marrow transplantation for leukaemia. Kolb HJ; Bender-Götze C Bone Marrow Transplant; 1990 Aug; 6(2):61-72. PubMed ID: 2207454 [TBL] [Abstract][Full Text] [Related]
60. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Heyll A; Meckenstock G; Aul C; Söhngen D; Borchard F; Hadding U; Mödder U; Leschke M; Schneider W Bone Marrow Transplant; 1994 Jul; 14(1):161-4. PubMed ID: 7951107 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]